Vir Biotechnology, Inc. — Director's Dealing 2020

Oct 14, 2020

SEC Form 4/A — Form 4/A

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2020-05-21

Reporting Person: SATO VICKI L (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-21	Stock Option (Right to Buy)	$37.06	A	23649	Acquired	2030-05-20	Common Stock (23649)	Direct